2024 Q3 Form 10-Q Financial Statement

#000143774924027186 Filed on August 19, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $1.624M $2.043M
YoY Change -39.99% -48.54%
Cost Of Revenue $1.265M
YoY Change -32.68%
Gross Profit $778.0K
YoY Change -62.79%
Gross Profit Margin 38.08%
Selling, General & Admin $1.589M $1.540M
YoY Change -11.62% -26.46%
% of Gross Profit 197.94%
Research & Development -$26.00K
YoY Change -166.67%
% of Gross Profit -3.34%
Depreciation & Amortization $29.00K
YoY Change -23.68%
% of Gross Profit 3.73%
Operating Expenses $2.500M $2.779M
YoY Change -27.49% -30.73%
Operating Profit -$876.0K -$736.0K
YoY Change 18.06% -1852.38%
Interest Expense -$156.0K
YoY Change -240.54%
% of Operating Profit
Other Income/Expense, Net -$146.0K -$231.0K
YoY Change -529.41% -412.16%
Pretax Income -$967.0K
YoY Change -3121.88%
Income Tax
% Of Pretax Income
Net Earnings -$1.022M -$967.0K
YoY Change 44.35% -3121.88%
Net Earnings / Revenue -62.93% -47.33%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 229.2M 229.3M
Diluted Shares Outstanding 242.6M 229.0M

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.085M
YoY Change 216.33%
Cash & Equivalents $601.0K $1.085M
Short-Term Investments
Other Short-Term Assets $196.0K
YoY Change -56.73%
Inventory $2.732M $3.203M
Prepaid Expenses
Receivables $84.00K $332.0K
Other Receivables $0.00
Total Short-Term Assets $3.936M $4.816M
YoY Change -32.18% 10.74%
LONG-TERM ASSETS
Property, Plant & Equipment $67.00K $91.00K
YoY Change -65.46% -60.61%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $101.0K $101.0K
YoY Change 0.0% 0.0%
Total Long-Term Assets $280.0K $411.0K
YoY Change -65.73% -56.69%
TOTAL ASSETS
Total Short-Term Assets $3.936M $4.816M
Total Long-Term Assets $280.0K $411.0K
Total Assets $4.216M $5.227M
YoY Change -36.32% -1.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.812M $1.626M
YoY Change 40.14% 66.43%
Accrued Expenses $1.454M
YoY Change 22.6%
Deferred Revenue $108.0K $238.0K
YoY Change -23.94% 226.03%
Short-Term Debt $1.514M
YoY Change 404.67%
Long-Term Debt Due $382.0K
YoY Change 232.17%
Total Short-Term Liabilities $5.328M $5.373M
YoY Change -6.23% 51.05%
LONG-TERM LIABILITIES
Long-Term Debt $150.0K
YoY Change -86.29%
Other Long-Term Liabilities $0.00
YoY Change -100.0%
Total Long-Term Liabilities $150.0K $150.0K
YoY Change -87.36% -88.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.328M $5.373M
Total Long-Term Liabilities $150.0K $150.0K
Total Liabilities $5.478M $5.523M
YoY Change -20.25% 13.32%
SHAREHOLDERS EQUITY
Retained Earnings -$11.57M -$10.55M
YoY Change 35.96% 35.2%
Common Stock $250.0K $250.0K
YoY Change 11.11% 11.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.262M -$296.0K
YoY Change
Total Liabilities & Shareholders Equity $4.216M $5.227M
YoY Change -36.32% -1.34%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$1.022M -$967.0K
YoY Change 44.35% -3121.88%
Depreciation, Depletion And Amortization $29.00K
YoY Change -23.68%
Cash From Operating Activities $131.0K
YoY Change -64.11%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 778.0K
YoY Change -292.1%
NET CHANGE
Cash From Operating Activities 131.0K
Cash From Investing Activities
Cash From Financing Activities 778.0K
Net Change In Cash 909.0K
YoY Change -2372.5%
FREE CASH FLOW
Cash From Operating Activities $131.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Cash
Cash
367000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
289000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
3826000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
604000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
5086000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
157000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
424000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
101000 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
682000 usd
CY2023Q4 us-gaap Assets
Assets
5768000 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3016000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2846000 usd
CY2024Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
79000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
223000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
355000 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
238000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
58000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5373000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4754000 usd
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
249602388
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
249602388
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
228535886
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
250000 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10006000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5227000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-1090000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5094000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8000000 usd
CY2024Q2 us-gaap Cash
Cash
1085000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
332000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
3203000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
4816000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
91000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
219000 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
101000 usd
CY2024Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
411000 usd
CY2024Q2 us-gaap Assets
Assets
5227000 usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1800000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1800000
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
229000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8204000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10552000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8540000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-296000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-107000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5768000 usd
chuc Cost Of Goods Sold Product Revenue
CostOfGoodsSoldProductRevenue
3372000 usd
chuc Cost Of Goods Sold Product Revenue
CostOfGoodsSoldProductRevenue
5018000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2968000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3763000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
451000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
687000 usd
us-gaap Operating Expenses
OperatingExpenses
6771000 usd
us-gaap Operating Expenses
OperatingExpenses
9559000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1677000 usd
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-75000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
35000 usd
CY2023Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
185000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
79000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
408000 usd
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001134765
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2019Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
196000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
73000 usd
CY2024Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
150000 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1121000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
5523000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
5875000 usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
228535886
chuc Research And Development Expense Reversal
ResearchAndDevelopmentExpenseReversal
-20000 usd
chuc Research And Development Expense Reversal
ResearchAndDevelopmentExpenseReversal
91000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1559000 usd
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
111000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
339000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
242000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
74000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-335000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
201000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
32000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2012000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1358000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
216372777
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
224795559
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
214987456
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
245299090
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
224795559
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
214987456
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1030000 usd
CY2024Q2 chuc Stock Issued During Period Value Debt Redemption
StockIssuedDuringPeriodValueDebtRedemption
676000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
1000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
56000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-967000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-296000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
355000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
0 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
37000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
32000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
424000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-107000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1030000 usd
chuc Stock Issued During Period Value Debt Redemption
StockIssuedDuringPeriodValueDebtRedemption
676000 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
-0 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
1000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
118000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2012000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-296000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1700000 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
0 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
82000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1358000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
424000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2012000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1358000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
10000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
85000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
66000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
80000 usd
us-gaap Accretion Expense
AccretionExpense
137000 usd
us-gaap Accretion Expense
AccretionExpense
132000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
79000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
408000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-75000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
35000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
205000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
182000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
117000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
82000 usd
us-gaap Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
531000 usd
us-gaap Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
118000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
53000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-554000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-623000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-621000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-466000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-327000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
170000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
117000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
180000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-75000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-205000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-180000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-300000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
124000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1030000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
630000 usd
chuc Proceeds From Notes Payable Related Party
ProceedsFromNotesPayableRelatedParty
500000 usd
chuc Proceeds From Notes Payable Related Party
ProceedsFromNotesPayableRelatedParty
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1018000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-38000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
718000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
86000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
367000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
257000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1085000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
343000 usd
us-gaap Interest Paid Net
InterestPaidNet
4000 usd
us-gaap Interest Paid Net
InterestPaidNet
145000 usd
chuc Interest Paid Net Related Party
InterestPaidNetRelatedParty
-90000 usd
chuc Interest Paid Net Related Party
InterestPaidNetRelatedParty
-15000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4000 usd
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0 usd
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
2000 usd
us-gaap Stock Issued1
StockIssued1
676000 usd
us-gaap Stock Issued1
StockIssued1
0 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
us-gaap Operating Income Loss
OperatingIncomeLoss
-1677000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2012000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-300000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-296000 usd
CY2024Q2 chuc Working Capital
WorkingCapital
557000 usd
CY2023Q4 chuc Working Capital
WorkingCapital
332000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i><span style="text-decoration: underline; ">Use of Estimates</span></i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:27pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</p>
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
79000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
79000 usd
CY2024Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0 usd
CY2019Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
27500000 usd
CY2019Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.44313
us-gaap Depreciation And Amortization
DepreciationAndAmortization
66000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
80000 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1036000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1036000 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
945000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
879000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
91000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
157000 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1626000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1472000 usd
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
546000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
573000 usd
CY2024Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
128000 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
128000 usd
CY2024Q2 chuc Customer Deposit Current
CustomerDepositCurrent
31000 usd
CY2023Q4 chuc Customer Deposit Current
CustomerDepositCurrent
386000 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
685000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
287000 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3016000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2846000 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
1126000 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
827000 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 usd
CY2024Q2 chuc Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
150000 usd
CY2024Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2103000 usd
CY2024Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
-57000 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
2046000 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-967000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
32000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2012000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1358000 usd
CY2024Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-0 usd
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
185000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-0 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-0 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-967000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-153000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-2012000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-1358000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228988755
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
216372777
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
224795559
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
214987456
CY2024Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
0
CY2023Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
28926313
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
0
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
0
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
228988755
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
245299090
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
224795559
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
214987456
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
73574000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
75076000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5272000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.58
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y3M18D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
624000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
1.44
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4648000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.46
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y3M18D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
4648000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
0.46
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
223000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
219000 usd
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
113000 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
113000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
225000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
225000 usd
CY2024Q2 us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
CY2024Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
113000 usd
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
113000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
225000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
225000 usd
CY2024Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
5000 usd
CY2023Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
5000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
10000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
10000 usd
CY2024Q2 us-gaap Lease Cost
LeaseCost
118000 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
118000 usd
us-gaap Lease Cost
LeaseCost
235000 usd
us-gaap Lease Cost
LeaseCost
235000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
226000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
202000 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y8M26D
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y6M29D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.12 pure
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.12 pure
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
159000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
75000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
234000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
11000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
223000 usd

Files In Submission

Name View Source Status
0001437749-24-027186-index-headers.html Edgar Link pending
0001437749-24-027186-index.html Edgar Link pending
0001437749-24-027186.txt Edgar Link pending
0001437749-24-027186-xbrl.zip Edgar Link pending
chuc-20240630.xsd Edgar Link pending
chuc20240630_10q.htm Edgar Link pending
ex_714433.htm Edgar Link pending
ex_714434.htm Edgar Link pending
ex_714435.htm Edgar Link pending
ex_714436.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
chuc-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
chuc20240630_10q_htm.xml Edgar Link completed
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
chuc-20240630_lab.xml Edgar Link unprocessable
chuc-20240630_def.xml Edgar Link unprocessable
chuc-20240630_cal.xml Edgar Link unprocessable